Medical Foods Market Size, Share & Trends Analysis Report By Route of Administration, By Product (Powder, Pills, Liquid, Other), By Application, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

Research Methodology

A three-pronged approach was followed for deducing the medical foods market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for medical foods market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of medical foods market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Medical Foods Market Categorization:

The medical foods market was categorized into five segments, namely route of administration (Oral, Enteral), product (Powder, Pills, Liquid), application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhoea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, Chronic Diarrhea, Constipation Relief, Protein Booster, Dysphagia, Pain Management, Parkinson's Disease, Epilepsy, Other Cancer related treatments, Severe Protein Allergy, Cancer, Cachexia), sales channel (Online Sales, Retail Sales, Institutional Sales), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The medical foods market was segmented into route of administration, product, application, sales channel, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The medical foods market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S., Canada, Germany, the UK., France, Italy, Spain, Sweden, Denmark, Norway, China, Japan, India, South Korea, Australia, Brazil, Mexico, Argentina, Saudi Arabia, UAE, Kuwait, Qatar and South Africa.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Medical foods market companies & financials:

The medical foods market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• Danone S.A.: Danone S.A. is one of the leading global food companies. It runs through four business segments, namely, early life nutrition, waters, fresh dairy products, and advanced medical nutrition. The company has a presence in more than 120 countries. Nutricia Advanced Medical Nutrition is a part of Danone Food Company that deals with nutritional solutions for diseased and aging population. The company’s offerings range across various conditions such as cancer, diabetes, lactose intolerance, metabolic disorders, and dysphagia. China, Turkey, and Latin America are some of the biggest markets for the company. Neocate Splash, Nutrini, and Nutrison are the company’s the top three medical nutrition brands.

• Nestlé S.A.: Nestlé S.A. is a leading nutrition, wellness, and healthcare brand founded 150 years ago. The company started as a condensed milk manufacturer and diversified into infant cereal, nutritional formulas, healthcare nutrition, weight management solutions, and food & beverages. The company boasts of more than 2,000 well-established brands and has manufacturing facilities across 85 countries. It sells and markets health foods under the brand name Nestlé Health Science, formed in 2011. Medical Nutrition is Nestlé Health Science’s largest business and one of its key focus areas is acute care with a wide range of nutritional solutions for critically ill and older people suffering from disease-related malnutrition.

• Abbott: Abbott is a biotechnology company involved in the worldwide development of in vitro diagnostic instrument systems and tests for hospitals, physician offices, reference laboratories, clinics, & blood banks. It offers hematology, automation, and transfusion instruments and immunochemistry reagents & tests for applications in the fields of cancer & cardiology, drugs of abuse, fertility, infectious diseases, retrovirus, therapeutic drug monitoring, and transplant. Its portfolio offerings are focused on the fields such as medical devices, diagnostics, nutritional products, and branded generic pharmaceuticals. The company has sales in more than 150 countries.

• Targeted Medical Pharma Inc.: Targeted Medical Pharma Inc. is a specialty pharmaceutical company that is dedicated to developing amino acid-based medications. The company is currently involved in developing patented amino acid-based medical foods, dietary supplements, and generic drugs to be distributed to physicians, patients, and pharmacies worldwide. It owns manufacturing facilities in the U.S. and is involved in selling its products in the U.S., Japan, Ukraine, China, Russia, and New Zealand among other countries. It partnered with various organizations in countries such as Ukraine, Hong Kong, Japan, Russia, and New Zealand for the development and distribution of products with patented core ingredient technology. It distributes its products through an internal sales staff and independent distributors across the U.S.

• Primus Pharmaceuticals, Inc.: Primus Pharmaceuticals, Inc. is a privately held company, involved in the manufacturing and selling of prescription medical food products. The company’s target customers include physicians in the fields such as rheumatology, pain management, orthopedics, gynecology, and dermatology. Its product portfolio caters to atopic dermatitis, osteoporosis/osteopenia, rheumatoid arthritis, and chronic venous disease, among others. Some of its popular brands include EpiCeram, Fosteum PLUS, Rheumate, and Vasculera. The company promotes its products to physicians through salesforce and co-promotion partnerships with other pharmaceutical organizations.

• Mead Johnson & Company, LLC: Mead Johnson & Company, LLC is engaged in manufacturing and marketing of products focused primarily on infant and child nutrition. In 2017, following the acquisition, the company became a wholly owned subsidiary of Reckitt Benckiser Group plc. The company runs through two major business segments, namely, Infant Formula and Children’s Nutrition. Their Enfa product line is one of the leading global infant nutrition brands. The company has around 70 products in over 50 countries, including China, Thailand, Malaysia, Indonesia, Vietnam, and, recently, India.

• Medtrition Inc.: Medtrition Inc. is a privately held company, formerly known as American Institutional Products Company of PA. It specializes in medical foods and has a presence in the medical foods industry for more than 30 years. The company’s instant food thickeners have revolutionized the dysphagia market. The company deals with medical foods for bowel management, oncology care, renal and liver disease, urinary tract infections, wound care, thickened dairy, protein & calorie malnutrition, and dysphagia. It serves more than 1,500 acute care facilities in more than 35 countries. Various healthcare professionals such as dieticians, nutritionists, and clinicians use this company’s products. They are also used in hospitals, wound care clinics, oncology centers, and dialysis centers.

• Fresenius Kabi AG: Fresenius Kabi AG is a subsidiary of Fresenius SE & Co. KGaA, a global healthcare group. Fresenius SE & Co. KGaA has independent business segments, including Fresenius Kabi, Fresenius Vamed, Fresenius Medical Care, and Fresenius Helios. It has presence in over 100 countries. Fresenius Kabi AG operates in various segments, including biosimilar, intravenous (IV) drugs, clinical nutrition, medical devices/transfusion technology, and infusion therapy. The company is involved in supplying transfusion technology products and medical devices. Its clinical nutrition segment includes products focusing on enteral nutrition, parenteral nutrition, and infusion disposables.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Medical Foods Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2023, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Medical Foods Market Report Assumptions:

• The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.